[Ip-health] Stat+ [paywall]: U.S. trade rep leans on Colombia to rework policies for access to medicines

Andrew Goldman andrew.goldman at keionline.org
Tue Feb 27 05:26:10 PST 2018


The USTR letter to Colombia Min. of Trade re OECD accession referred to in
the article below is available here:
http://freepdfhosting.com/fcc8c52a0d.pdf--
https://www.statnews.com/pharmalot/2018/02/26/trade-rep-colombia-patents-access/
U.S. trade rep leans on Colombia to rework policies for access to medicinesBy
ED SILVERMAN @Pharmalot

FEBRUARY 26, 2018

<snip>

In a Feb. 14 letter, Robert Lighthizer wrote to the Colombian trade
minister that “key stakeholders remain dissatisfied” with government
policies. The letter was sent as a meeting nears this month, according to
sources, to discuss membership in the Organization for Economic Cooperation
and Development, an intergovernmental group of three dozen countries that
was created to stimulate economic progress and world trade.

At issue is the approach taken by Colombian officials to endorsing patents
on medicines in general, as well as approving biosimilars, nearly identical
variants of brand-name biologic medicines that are expected to provide the
same result in patients, but at a lower cost. The pharmaceutical industry
contends that Colombia fails to properly protect its intellectual property
and creates access barriers.
<snip>


--
Andrew S. Goldman
Counsel, Policy and Legal Affairs
Knowledge Ecology International
andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
tel.: +1.202.332.2670 <(202)%20332-2670>
www.keionline.org


More information about the Ip-health mailing list